Support for Rare Disease Drugs Extended Until 2027
This bill extends a program that supports the development of drugs for rare diseases, known as orphan drugs. This means individuals suffering from rare conditions may have greater hope for access to necessary treatments. Extending funding until 2027 ensures the continuity of research and production of these crucial medications.
Key points
The program supporting the development of drugs for rare diseases (orphan drugs) has been extended for another five years, until 2027.
This funding extension ensures continued research and availability of medications for people with rare conditions.
Expired
Citizen Poll